Butterfly Pivotal Study
A Prospective, Randomized, Controlled, Blinded Study to Assess the Safety and Efficacy of the Butterfly Medical Prostatic Retraction Device in BPH Patients
Sponsor: Butterfly Medical Ltd.
Listed as NCT05341661, this NA trial focuses on BPH (Benign Prostatic Hyperplasia) and Lower Urinary Tract Symptoms (LUTS) and remains ongoing. Sponsored by Butterfly Medical Ltd., it has been updated 8 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Feb 2025 — Present [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Dec 2024 — Feb 2025 [monthly]
Recruiting NA
-
Sep 2024 — Dec 2024 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Sep 2023 — Jul 2024 [monthly]
Recruiting NA
▶ Show 3 earlier versions
-
Jul 2022 — Sep 2023 [monthly]
Recruiting NA
Status: Active Not Recruiting → Recruiting
-
Jun 2022 — Jul 2022 [monthly]
Active Not Recruiting NA
Status: Withheld → Active Not Recruiting · Phase: None → NA
-
May 2022 — Jun 2022 [monthly]
Withheld
First recorded
Apr 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Butterfly Medical Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .